Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:25789755  

Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.

Brenda Huang | WenJie Wei | Guohao Wang | Marta A Gaertig | Yue Feng | Wei Wang | Xiao-Jiang Li | Shihua Li
Neuron | 2015

Growing evidence indicates that non-neuronal mutant huntingtin toxicity plays an important role in Huntington's disease (HD); however, whether and how mutant huntingtin affects oligodendrocytes, which are vitally important for neural function and axonal integrity, remains unclear. We first verified the presence of mutant huntingtin in oligodendrocytes in HD140Q knockin mice. We then established transgenic mice (PLP-150Q) that selectively express mutant huntingtin in oligodendrocytes. PLP-150Q mice show progressive neurological symptoms and early death, as well as age-dependent demyelination and reduced expression of myelin genes that are downstream of myelin regulatory factor (MYRF or MRF), a transcriptional regulator that specifically activates and maintains the expression of myelin genes in mature oligodendrocytes. Consistently, mutant huntingtin binds abnormally to MYRF and affects its transcription activity. Our findings suggest that dysfunction of mature oligodendrocytes is involved in HD pathogenesis and may also make a good therapeutic target.

Pubmed ID: 25789755

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS041669
  • Agency: NINDS NIH HHS, United States
    Id: NS045016
  • Agency: NINDS NIH HHS, United States
    Id: NS041669
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019206
  • Agency: NIMH NIH HHS, United States
    Id: MH/NS 31862
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS095181
  • Agency: NIA NIH HHS, United States
    Id: AG019206
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS045016
  • Agency: NIA NIH HHS, United States
    Id: P50-AG025688
  • Agency: NIA NIH HHS, United States
    Id: R01 AG031153
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS056097
  • Agency: NCI NIH HHS, United States
    Id: P30 CA138292
  • Agency: NIA NIH HHS, United States
    Id: P50 AG025688
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS036232
  • Agency: NINDS NIH HHS, United States
    Id: NS036232
  • Agency: NCI NIH HHS, United States
    Id: P30CA138292
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS070526
  • Agency: NIA NIH HHS, United States
    Id: AG31153

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Gene Expression Omnibus (GEO) (tool)

RRID:SCR_005012

Functional genomics data repository supporting MIAME-compliant data submissions. Includes microarray-based experiments measuring the abundance of mRNA, genomic DNA, and protein molecules, as well as non-array-based technologies such as serial analysis of gene expression (SAGE) and mass spectrometry proteomic technology. Array- and sequence-based data are accepted. Collection of curated gene expression DataSets, as well as original Series and Platform records. The database can be searched using keywords, organism, DataSet type and authors. DataSet records contain additional resources including cluster tools and differential expression queries.

View all literature mentions